From January 15-21, 2017, 44 trainees gathered in Stony Point, New York, to participate in Part B of the MDMA Therapy Training Program. The five-part training program is currently preparing therapy teams for upcoming MAPS-sponsored Phase 3 clinical trials of MDMA-assisted psychotherapy for PTSD. Part B of the program is a week-long training led by MAPS-sponsored researchers Michael Mithoefer, M.D., Annie Mithoefer, B.S.N., and Marcela Ot’alora, M.A., L.P.C. The program is a prerequisite for anyone working on a therapy team in a MAPS-sponsored Phase 3 trial. All Phase 3 researchers will also complete Parts C-E of the training program, which include an external workshop, a second week-long training, a final evaluation, and clinical supervision. At this point, the training program is not accepting applications, however you can sign up to receive updates when future training opportunities become available. Sign up and learn more…
